Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical Trial.

Autor: Wong JS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Uno H; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Tramontano AC; Dana-Farber Cancer Institute, Boston, Massachusetts., Fisher L; Dana-Farber Cancer Institute, Boston, Massachusetts., Pellegrini CV; Dana-Farber Cancer Institute, Boston, Massachusetts., Abel GA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Burstein HJ; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Chun YS; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., King TA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Schrag D; Memorial Sloan Kettering Cancer Center, New York, New York., Winer E; Yale Cancer Center, New Haven, Connecticut., Bellon JR; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Cheney MD; Maine Medical Center, Portland, Maine., Hardenbergh P; Vail Health, Vail, Colorado., Ho A; Duke University Medical Center, Durham, North Carolina., Horst KC; Stanford University School of Medicine, Stanford, California., Kim JN; Fred Hutchinson Cancer Center/UW Medicine, Seattle, Washington., Leonard KL; Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Rhode Island Hospital, Providence., Moran MS; Yale Cancer Center, New Haven, Connecticut., Park CC; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Recht A; Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Soto DE; Massachusetts General Hospital, Boston., Shiloh RY; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Stinson SF; Johns Hopkins School of Medicine, Baltimore, Maryland., Snyder KM; Northern Light Health, Brewer, Maine., Taghian AG; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston., Warren LE; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Wright JL; Johns Hopkins School of Medicine, Baltimore, Maryland., Punglia RS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.

Publikováno v: JAMA oncology [JAMA Oncol] 2024 Oct 01; Vol. 10 (10), pp. 1370-1378.